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Abstract: Biofluids that contain stable calcium phosphate nanoclusters sequestered by phosphopeptides
make it possible for soft and hard tissues to co-exist in the same organism with relative ease. The stability
diagram of a solution of nanocluster complexes shows how the minimum concentration of phosphopeptide
needed for stability increases with pH. In the stable region, amorphous calcium phosphate cannot
precipitate. Nevertheless, if the solution is brought into contact with hydroxyapatite, the crystalline phase
will grow at the expense of the nanocluster complexes. The physico-chemical principles governing the
formation, composition, size, structure, and stability of the complexes are described. Examples are given
of complexes formed by casein, osteopontin, and recombinant phosphopeptides. Application of these
principles and properties to blood serum, milk, urine, and resting saliva is described to show that under
physiological conditions they are in the stable region of their stability diagram and so cannot cause soft
tissue calcification. Stimulated saliva, however, is in the metastable region, consistent with its role in tooth
remineralization. Destabilization of biofluids, with consequential ill-effects, can occur when there is a
failure of homeostasis, such as an increase in pH without a balancing increase in the concentration of
sequestering phosphopeptides.
Keywords: calcium phosphate; biocalcification; phosphoprotein; serum; milk; saliva; urine
1. Introduction
Understanding the mechanisms of biocalcification and the chemistry of the resulting mineral
phases of hard tissues has been the subject of several excellent recent reviews [1–11]. In these reviews,
extensive coverage is given to the effects of proteins, particularly phosphoproteins on the control of
biomineralization but overwhelmingly, studies have been made on the effects observed at low molar
ratios of the phosphoprotein to calcium phosphate. In this review, we concentrate on the functions of
complexes formed between intrinsically disordered phosphoproteins or phosphopeptides (IDPs) and
calcium phosphate (CaP) at higher molar ratios where the complexes formed are thermodynamically
stable, or at least stable for a long time (Figure 1).
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Figure 1. Maintaining a balance between soft and hard tissues: role of sequestered forms of 
amorphous calcium phosphate nanoclusters in the control of biocalcification. With excess of certain 
phosphoproteins or phosphopeptides (Table 1), stable solutions containing calcium and Pi can remain 
in contact with soft tissues without causing the tissue to become calcified. The concentration of the 
nanocluster complexes can be arbitrarily high, as in milk. A similar solution, in contact with a hard 
tissue, such as bone or tooth, can act as a reservoir of ions for mineralization of the tissue. 
Hydroxyapatite (HA), or apatite, is a basic CaP mineral present in hard tissues such as bone, 
cementum, dentine, and enamel. Apatite was named by geologists from the Greek word apate 
meaning deceive because of the variable crystal habit and composition of apatite rocks. Soft tissues 
and most biofluids, by contrast, contain little or no mineral in their normal, physiological state. Soft 
tissues can become mineralized and hard tissues can become demineralized as a result of 
degenerative, dysfunctional, or diseased conditions. However, under physiological conditions, soft 
tissues remain soft and hard tissues remain hard, even though they are permeated by the same 
extracellular fluid. The challenge posed by the co-existence of soft and mineralized tissues in the same 
organism can be phrased in chemical terms. For the hard tissue to stay mineralized the permeating 
biofluid must be at least saturated with respect to the hard tissue mineral and yet, for the soft tissues 
and biofluids to remain unmineralized, the permeating biofluid must be stable. Studies on solutions 
containing sequestered amorphous CaP complexes, including milk and other biofluids, showed that 
they were undersaturated with respect to the first-formed amorphous phase but supersaturated with 
respect to more crystalline forms of CaP [12,13]. Thus, the solutions and the nanocluster complexes 
within them are stable. If the solutions are brought into contact with a crystalline form of CaP, the 
more stable crystalline phase will tend to grow at the expense of the nanocluster complexes. 
A solution to the problem of the stability of biofluids and the co-existence of soft and mineralized 
tissues must have been found more than about 500 million years ago when the first calcium carbonate 
or phosphate mineralized tissues appear in the fossil record. These include the cone-shaped denticles 
or teeth of extinct agnathan chordates resembling eels, called conodonts. By about 50 million years 
later, homologues of the modern hard tissue types were established. For example, the bone-like head 
plates of placoderms may have allowed sense organs, mounted on this stable platform to build up a 
three-dimensional picture of their environment. Concomitantly, a paralogous group of 
phosphoproteins evolved called SCPPs (secreted calcium- or CaP-binding phosphoproteins) [14–16]. 
Members of this group of proteins are seemingly involved in every aspect of biomineralization. One 
of the earliest members of the group of SCPPs was osteopontin (OPN) which has a very wide 
occurrence in the tissues and biofluids of chordate species [17]. 
Caseins are also SCPPs. It has been known for many years that the CaP nanoclusters of casein 
micelles allow stable milk to be formed containing much higher calcium and phosphate 
concentrations than the solubility of inorganic CaPs at milk pH. Because of the ready availability of 
milk, the high concentrations of the caseins responsible for its stability and the study of artificial 
Figure 1. Maintaining a balance between soft and hard tissues: role of sequestered forms of amorphous
calcium phosphate nanoclusters in the control of biocalcification. With excess of certain phosphoproteins
or phosphopeptides (Table 1), stable solutions containing calcium and Pi can remain in contact with soft
tissues without causing the tissue to become calcified. The concentration of the nanocluster complexes
can be arbitrarily high, as in milk. A similar solution, in contact with a hard tissue, such as bone or
tooth, can act as a reservoir of ions for mineralization of the tissue.
Hydroxyapatite (HA), or apatite, is a basic CaP mineral present in hard tissues such as bone,
cementum, dentine, and enamel. Apatite was named by geologists from the Greek word apate meaning
deceive because of the variable crystal habit and composition of apatite rocks. Soft tissues and most
biofluids, by contrast, contain little or no mineral in their normal, physiological state. Soft tissues
can become mineralized and hard tissues can become demineralized as a result of degenerative,
dysfunctional, or diseased conditions. However, under physiological conditions, soft tissues remain
soft and hard tissues remain hard, even though they are permeated by the same extracellular fluid.
The challenge posed by the co-existence of soft and mineralized tissues in the same organism can be
phrased in chemical terms. For the hard tissue to stay mineralized the permeating biofluid must be
at least saturated with respect to the hard tissue mineral and yet, for the soft tissues and biofluids
to remain unmineralized, the permeating biofluid must be stable. Studies on solutions containing
sequestered amorphous CaP complexes, including milk and other biofluids, showed that they were
undersaturated with respect to the first-formed amorphous phase but supersaturated with respect
to more crystalline forms of CaP [12,13]. Thus, the solutions and the nanocluster complexes within
them are stable. If the solutions are brought into contact with a crystalline form of CaP, the more stable
crystalline phase will tend to grow at the expense of the nanocluster complexes.
A solution to the problem of the stability of biofluids and the co-existence of soft and mineralized
tissues must have been found more than about 500 million years ago when the first calcium carbonate
or phosphate mineralized tissues appear in the fossil record. These include the cone-shaped denticles
or teeth of extinct agnathan chordates resembling eels, called conodonts. By about 50 million years
later, homologues of the modern hard tissue types were established. For example, the bone-like
head plates of placoderms may have allowed sense organs, mounted on this stable platform to
build up a three-dimensional picture of their environment. Concomitantly, a paralogous group of
phosphoproteins evolved called SCPPs (secreted calcium- or CaP-binding phosphoproteins) [14–16].
Members of this group of proteins are seemingly involved in every aspect of biomineralization. One of
the earliest members of the group of SCPPs was osteopontin (OPN) which has a very wide occurrence
in the tissues and biofluids of chordate species [17].
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Table 1. Selected known or potential CaP-SLiMs formed by the action of the Golgi kinase FAM20C on secreted phosphoproteins 1.
1 Sequence numbers are for the mature peptide chain without the signal sequence. Known phosphorylation sites and sites predicted for the canonical recognition sequences of FAM20C are
in boldface red.
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Caseins are also SCPPs. It has been known for many years that the CaP nanoclusters of casein
micelles allow stable milk to be formed containing much higher calcium and phosphate concentrations
than the solubility of inorganic CaPs at milk pH. Because of the ready availability of milk, the high
concentrations of the caseins responsible for its stability and the study of artificial nanocluster complexes
made with pure phosphopeptides, we have been able to gain a detailed understanding of the reasons for
its stability. These insights have led to a hypothesis, supported by indirect experimental evidence that
essentially the same mechanism but with different phosphoproteins, stabilizes other, supersaturated,
biofluids. Ideas about biofluid stability are important not only for understanding the control of
physiological calcification, but also for the development of effective treatments for the diseases of
pathological calcification. We review the literature on the composition, structure and stability of
equilibrium CaP nanocluster complexes with phosphoproteins with emphasis on the last 26 years since
the first artificial complexes made with a pure phosphopeptide were described [18].
In this review, we will use stability to mean exclusively stability with respect to the precipitation
of CaP. A metastable solution is one that shows no obvious sign of precipitation for some time
but is not thermodynamically stable. The term CaP nanocluster complex applies to the core CaP
nanocluster and its shell of sequestering phosphopeptides and can be abbreviated to nanocluster
complex. CaP nanocluster is synonymous with the older term from the dairy literature of colloidal
calcium phosphate but neither CaP nanoclusters nor colloidal calcium phosphate are known as stable
independent particles. Protein and peptide are used interchangeably, and residue numbers apply to
the mature peptide after cleavage of the signal sequence. The term competent phosphopeptide means
one capable, in principle, of forming an equilibrium nanocluster complex in a thermodynamically
stable solution if it is present at a high enough concentration. Structural requirements of a competent
phosphopeptide are known only incompletely so they are defined by examples such as the ones in this
review. Molar and molal concentrations are in units of moles per liter of solution and moles per 1000 g
of water, respectively. Where a numerical value is quoted with a confidence interval, it is the mean and
estimated standard deviation. We will refer to a solution of nanocluster complexes while recognizing
that it could equally well be called a dispersion.
2. Role of IDPs in the Control of Biocalcification
The need for organisms to form ordered, functional, mineralized tissue while simultaneously
preventing unwanted calcification of soft tissue, requires strict control of the biocalcification process.
In vivo biocalcification is a hierarchical process influenced by many factors including proteins, salts,
lipids, and sugars, but the main emphasis in this review is on the effects of proteins on the formation of
calcium phosphate phases from various biofluids. Phase separation can be divided into three main
stages: nucleation, usually as an amorphous substance, growth and maturation of composition and
structure to give a more-or-less crystalline morphology [19–21]. Each stage of the biocalcification
process is influenced by a range of non-collagenous proteins, the vast majority of which are acidic
IDPs [9,11,19,22]. IDPs are characterized by the lack of a well-defined solution structure over much of
their sequence. Instead, they rapidly sample an ensemble of interchangeable, dynamic, conformations.
Because of their dynamic nature, IDPs tend to interact with ligands and other proteins through short
linear functional motifs, or SLiMs [23]. Typically, SLiMs comprise 3–10 consecutive residues that
act together to form weak and reversible interactions with their targets. A single IDP may contain
several SLiMs of the same or different types and these confer on the IDP many of its key properties.
Not rarely, the affinity of a SLiM for its target can be modulated by secondary modifications such as
phosphorylation, sometimes by several orders of magnitude. In this review, the main focus will be on
SCPPs [15] which are usually phosphorylated, and all are known or predicted IDPs [11,22,24,25].
2.1. Secreted Calcium- or Calcium Phosphate-Binding Proteins
The paralogous group of SCPPs are thought to have evolved by gene duplication and in humans
are mostly found on chromosome 4 apart from amelogenin, located on the non-autosomal parts of
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the sex chromosomes [15,16]. They share a similar intron/exon gene structure and several functional
motifs despite considerable sequence divergence at the level of the mature protein [26]. For example,
the highly acidic SIBLING subgroup (small integrin-binding ligand N-linked glycoprotein) [27] all
contain the integrin receptor-binding motif RGD whereas the non-SIBLINGs contain Pro- and Gln-rich
(P,Q-rich) sub-sequences. The P,Q-rich sequences are weakly interacting flexible linkers punctuated by
functional motifs such as short sequences of hydrophobic and order-promoting residues (HO-SLiMs).
Other motifs include the CaP-SLiMs and short cationic or anionic sequences that promote attractive,
electrostatic, protein-protein interactions [28]. Through a range of different types of interactions
mediated by their SLIMs, the non-SIBLING SCPPs have a tendency to associate to form homotypic or
heterotypic oligomers or larger assemblies such as gels or amyloid fibrils and ribbons [28–34].
Genes in the SIBLING group include the bone and tooth associated DMP1 (dentin matrix protein
1), DSPP (dentin sialophosphoprotein), IBSP (integrin-binding bone sialophosphoprotein) encoding
BSP (bone sialophosphoprotein), MEPE (matrix extracellular phosphoglycoprotein) and the more
widely expressed SPP1 (secreted phosphoprotein 1) which encodes OPN. The non-SIBLING genes
encode, among others, the casein family of milk proteins, the salivary proteins statherin and three
proline-rich proteins, and the tooth proteins enamelin and amelogenin.
2.2. Calcium Phosphate-Binding Short Linear Motifs (CaP-SLiMs)
The CaP-SLiMs are short sequences phosphorylated at several, sometimes adjacent, sites.
They commonly also contain a variable number of Asp or Glu residues and (usually) seryl residues
in protein kinase recognition sequences. The Golgi kinase consensus recognition sequences include
S-X-E/pS where X is any residue and pS is phosphoserine with the result that sequences of consecutive
phosphorylated residues can be created from, for example, S-S-S-E-E. A sequence of three consecutive
phosphoseryl residues creates a high-affinity binding site for Ca2+ and H+ [35–39] and a higher
affinity of binding to CaP than the same number of phosphorylated residues in a more extended
CaP-SLiM [38,40]. Biocalcification processes can be controlled precisely by varying the sequences
of CaP-SLiMs, their degree of phosphorylation and the concentration and composition of the
non-collagenous phosphoproteins in the extracellular milieu [1,41–43].
Within the SIBLING subgroup of SCPPs, the CaP-SLiMs have been called ASARM (acidic serine
and aspartate-rich motif) sequences but in general, glutamate usually predominates over aspartate.
Similar sequences in caseins have been called phosphate centers. The MEPE ASARM peptide is at the
C-terminus and can be cleaved from the protein by the action of cathepsin B [44]. The human sequence,
shown in Table 1, contains 9 seryl residues and when the peptide is co-expressed in epithelial cells
with the Golgi kinase FAM20C, up to 9 seryl residues can be phosphorylated [45]. The phosphorylated
peptide is an inhibitor of in vivo and in vitro mineralization [44,46,47]. In a survey of ASARM-like
sequences among SIBLINGS [48], 20 were identified in DSPP, four in DMP1, one in BSP, and three
in OPN. However, the phosphophoryn region in the C-terminal half of DSPP contains many more
ASARM-like tandem repeats. A few examples of CaP-SLiM sequences are shown in Table 1. Among the
non-SIBLING SCPPs, conserved CaP-SLIMs are common in five of the six known casein gene products
but are rare or absent in κ-caseins (Table 1). Statherin contains a CaP-SLiM near its N-terminus in
which two consecutive residues are normally phosphorylated [49]. Other candidates are identified for
enamelin (ENAM), ameloblastin (AMBN), amelotin (AMTN) and odontogenic ameloblastin-associated
protein (ODAM). Also included in Table 1 are some sequences from non-SCPP proteins. These include
Fetuin A (FETUA), secreted phosphoprotein 24 (SPP24) and matrix Gla-protein (MGP) which have been
associated with calcified bodies from blood serum, and the basic salivary proline-rich protein (PRB4).
CaP-SLiMs are therefore prevalent in many of the proteins involved in the control of biocalcification.
They occur in all the phosphoproteins and phosphopeptides known to sequester CaP nanoclusters
and may be essential. Their precise function is discussed further in Sections 3 and 4. In particular,
in Section 4.3 experimental evidence is given to show that increasing the number and proximity of
phosphorylated residues in a CaP-SLiM increases its affinity for CaP. Longer sequences of consecutive
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phosphorylated residues may contain additional, high-affinity, binding sites for cations, and have an
even higher affinity for CaP. The bone acidic glycoprotein-75 has a remarkable ability to bind many
phosphate ions with high affinity, suggesting that it has specific binding sites for the anion [50]. Similar
anion binding sites may be important also in the binding of CaP. The CaP-SLiMs in Table 1 do not
appear to contain or flank any of the recognized motifs associated with binding phosphate anions
such as anion nests or P-loops containing a basic residue (GXXXXGK(S,T)) [51–53]. The involvement
of basic residues in the folding and binding of the N-terminal region of statherin to HA has been
reported [54–56]. However, much more work is needed to investigate the potential co-binding to
calcium and Pi ions in the CaP by basic and acidic residues in or around the CaP-SLiM sequences.
2.3. Conformational Flexibility and Adaptability
The observed preponderance of IDPs in biocalcification is due to several key physical properties
that provide functional advantages compared to globular proteins. One of the first proposals for
a physiological role for IDPs was in the control of biocalcification [57,58]. It was suggested that
conformational flexibility allowed the protein to bind to and modulate the further growth of CaP
nuclei at a more rapid rate than would be possible for a more rigid protein. Since then there have
been many other proposals for biological functions for IDPs, including diverse roles in biocalcification.
For example, flexible IDPs can adapt their conformation to achieve a higher density of CaP-SLiMs
than could be achieved by a more rigid globular protein of the same size (Figure 2). Thus, individual
phosphopeptides with a single CaP-SLiM may pack together tightly. A protein with several CaP-SLiMs
may form loops and trains on the surface of CaP. Alternatively an IDP such as phosphophoryn with
very many tandem CaP-SLiMs may adopt a sessile conformation so that many of its CaP-SLiMs
bind to the surface [59,60]. The behavior of phosphophoryn may be compared to that of a synthetic
polyelectrolyte adsorbed onto a surface of opposite charge where the conformation adopted depends
on an interplay between the adsorbed polymers and between the polymers and the surface [61].
The N-terminal OPN 1–149 has a flexible, adaptable, conformation containing three CaP-SLiMs
(see Table 1), each of which binds to the CaP nanocluster core [24,62]. These interactions would be
sterically forbidden/less favorable if the CaP-SLiMs were part of a rigid or globular protein. Another
example of the modulation of CaP precipitation is provided by the acidic proline-rich proteins (PRPs)
of saliva. Their two sites of phosphorylation are not close together in the sequence, so they occupy
a larger surface area of hydroxyapatite per protein molecule than the other main salivary inhibitor,
statherin [63]. The CaP-SLiM of statherin, as with many of the other examples in Table 1 is formed
from phosphorylation sites close together in the sequence [63,64]. In Section 3.5 we show that the
surface area per CaP-SLiM is an important parameter determining the equilibrium size and free energy
of formation of nanocluster complexes with phosphoproteins. In Section 4, several examples are given
of nanocluster complexes where a high density of CaP-SLiMs is achieved at the core surface either by
close packing of short peptides containing a single CaP-SLiM or through the flexible and adaptable
conformation of a longer sequestering phosphopeptide containing several CaP-SLiMs.
The collapse of IDPs into a more compact conformation is disfavored by the prevalence of charged
and neutral hydrophilic residues in these proteins [65]. The net charge of extracellular acidic IDPs
may be further increased in vivo by phosphorylation during secretion via the Golgi route, mainly
by the kinase Fam20C [66–68]. The natural abundance of charged amino acids combined with
the increased prevalence of phosphorylated residues, facilitates the interaction between IDPs and
mineral surfaces [4,11,69]. The dentin matrix phosphoprotein 1 (DMP1) provides an example of the
importance of phosphorylation for the interaction of an IDP with mineral surfaces. The extent of
phosphorylation of the protein determines whether it has an inhibitory or promoting effect on the
growth of HA [70]. Indeed, the apparently contradictory effects, of either promoting or inhibiting HA
growth, depending on the presence of phosphorylated residues, has been observed in several other
IDPs involved in the process of biocalcification, including the salivary IDP statherin [71], the tooth
maturation protein amelotin [72], bone phosphophoryn [73], bone sialoprotein [74] and OPN [75,76].
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Although it is generally considered an inhibitor of mineralization it was shown that OPN could
promote the intrafibrillar mineralization of collagen [41].
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The interaction between the charged residues of IDPs and mineralized surfaces can, in some
instances, induce or stabilize specific secondary structures. For example, the N-terminal region of
statherin adopts an α-helical conformation upon absorption to mineral surfaces [54,55]. It has been
suggested that this folding upon binding prevents further growth of HA by shielding the surface of
the mineral phase from further addition of CaP [54]. Folding-upon-binding events of IDPs may induce
secondary structure elements that recruit other proteins involved in the biocalcification process to the
mineral surface.
Another key advantage of IDPs in the regulation of biocalcification is their rapid sampling of a
large conformational space, which results in an acceleration of protein-ligand interactions [57,58,77].
In the sequestration of CaP nanoclusters, this flexibility provides a mechanism through which the
protein can rapidly react with nucleating clusters of amorphous calcium phosphate (ACP), to prevent
or slow the irreversible formation of more crystalline phases [57,58]. Slower sequestration resulting
from a low affinity of binding, a low concentration of sequestrant or a more rigid conformation may
result in the irreversible formation of crystalline, or poorly crystalline, CaP.
In summary, all proteins that sequester ACP have been found to have two key properties. First,
they contain at least one CaP-SLiM and second, they lack a well-defined conformation. The lack
of a well-defined globular conformation may be beneficial, if not a prerequisite, for stable CaP
nanocluster complexes.
3. Basic Science of Amorphous Calcium Phosphate Sequestration by Phosphoproteins
The control of CaP (or calcium carbonate [4]) biocalcification by acidic IDPs is critically dependent
on the formation of amorphous precursor complexes where the free energy of binding of the protein
is at least comparable to the free energy of forming molecular clusters, nuclei, or nanoclusters of
the mineral.
3.1. Ostwald Rule of Stages and Non-Classical Nucleation of Calcium Phosphate
At physiological pH, CaP does not precipitate directly from solution as the most thermodynamically
stable phase, HA. Instead, according to the Oswald rule of stages [78–81], precipitation passes through
several unstable or metastable stages from the most soluble to the least, as shown in Figure 3. However,
Ostwald’s rule is not a universal law and local minima separated by an activation free energy may
exist to prevent the achievement of the lowest free energy state within a reasonable time. Some of these
enduring, but in principle transient states, involving amorphous precursors of crystalline substances,
are exploited in biology [7,82].
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Figure 3. Effect of phosphopeptides on the free energy changes during the precipitation and maturation
of CaP from a supersaturated solution. (a) In the absence of the phosphopeptide (curve A), nuclei of
amorphous CaP form during the lag phase and grow into a precipitate of ACP-1 which matures into
ACP-2, and further matures to form a poorly crystalline or crystalline phase. Adding a phosphopeptide
at any point in the reaction up to the stage where the ACP begins to mature into a crystalline form
generates a local free energy minimum (curves B and C) and an activation free energy barrier to slow
or stop further maturation. The position of the minimum, the composition of the sequestered ACP and
the size of the nanocluster particles depend on the affinity of the phosphopeptide for the CaP (Kseq),
its concentration in the continuous phase at equilibrium (a0,1) and other factors. (b) The phosphopeptide
can act as an inhibitor and as a nucleator of CaP precipitation, either increasing or decreasing the time
spent in the lag phase, depending on which effect predominates. For a given phosphopeptide the
course of the reaction can be expressed in terms of the value of the product Kseqa0,1. (A) Homogeneous
nucleation in the presence of a non-binding phosphopeptide or heterogeneous nucleation at a very
high molar ratio of CaP to phosphopeptide. Effectively, Kseqa0,1 << 1 (curve (A) in (a)) and the ACP
matures to form a (poorly) crystalline CaP. (B) An intermediate situation (0 < Kseqa0,1 < 1) (curve (B)
in (a)) in which competent sequestering phosphopeptides are present and form kinetically stabilized
complexes with CaP to decrease (in this example) or increase the time spent in the lag phase, but the
activation free energy barrier is not large enough to prevent further growth and maturation of the ACP.
(C) For Kseqa0,1 ≥ 1(curve (C) in (a)), the activation free energy is large enough for stable nanocluster
complexes to form in a local free energy minimum and reach an equilibrium size and composition.
Their formation may occur reversibly, starting from either a supersaturated solution or by adding the
phosphopeptide to a pre-formed phase of ACP. (b) reproduced with permission from Holt et al. [24]
©2009FEBS.
It has been recognized for many years that an initial and highly unstable amorphous phase,
ACP-1 is succeeded by a more stable and less soluble amorphous phase, ACP-2 [83,84]. Both phases
have the same Ca/Pi ratio of 1.35 which is significantly lower than that of a basic tricalcium phosphate
(Ca/Pi = 1.5) but above that of an acidic dicalcium phosphate (Ca/Pi = 1.0). The empirical chemical
formula Ca(PO4)0.52(HPO4)0.22 is consistent with an ACP of Ca/Pi = 1.35 [83]. In similar studies [84–87],
the Ca/Pi ratio of ACP has been reported to be as high as 1.5 [88] and as low as 1.18 [87], demonstrating
that a range of more-or-less acidic ACP phases are possible with distinct short-range structures [89–91].
The variable co-ordination geometry of calcium ions in calcium salts and variable stoichiometry of
CaPs are well recognized [92]. For example in the crystalline dicalcium phosphates three structures
have been reported of anhydrous, monohydrate and, dihydrate salts [93].
Maturation of ACPs often proceeds by a mechanism called solution-mediated solid-to-solid
transformation [2,94,95] in which a less soluble phase gradually dissolves, its ions pass into solution
where a less soluble phase nucleates and grows. The transformation rate depends on many factors,
including the addition of seed crystals and the solution concentration of effective inhibitors such as
ions of magnesium, citrate, phosphonates, or phosphate esters such as phosphoproteins [1,2]. Usually,
ACP matures first at neutral or alkaline pH into poorly crystalline, impure, and non-stoichiometric
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phases, the more stoichiometric octacalcium phosphate and the most stable, least soluble crystalline
phase, HA [96]. The mineralized tissues of bone, cementum, and dentine all contain poorly crystalline
CaPs with carbonate substitutions for the other anions. Even so, the surface of bone is not a highly
insoluble apatite-type phase but a highly hydrated layer, rich in hydrogen phosphate ions [97].
This surface layer is in dynamic exchange with the extracellular matrix where biomolecule-ion-mineral
interactions take place. Tooth enamel comprises highly crystalline prisms of almost pure HA in contact
with re-mineralizing saliva [98].
3.2. Effect of Phosphopeptides
Phosphoproteins and phosphopeptides can affect every aspect of the precipitation process by
acting as either heterogeneous nucleators of an amorphous or crystalline CaP or as partial inhibitors
to produce a metastable solution of colloidal complexes with CaP or to form a thermodynamically
stable solution of sequestered CaP nanoclusters [1,11]. The outcome depends on the concentration of
the phosphoprotein, the concentration of CaP precipitating from the supersaturated solution and the
affinity of the phosphopeptide for the CaP under the conditions of pH and other ion concentrations
in the solution. Clearly, inhibition or nucleation properties are not intrinsic to a given protein and it
should not be considered surprising that it can act in various ways, depending on its concentration,
other solution conditions and its degree and pattern of phosphorylation. The absence of phosphorylated
residues may allow the default process of ACP maturation by Ostwald ripening to proceed more
quickly than with a phosphorylated form. On the other hand, phosphorylated sequences may nucleate
CaP and if the molar ratio of CaP to nucleating agent is high, then the initial ACP may mature into a
crystalline phase. If the molar ratio is lower, the nucleating agent may also inhibit maturation and
the solution may remain in a lag phase, sometimes with little change in appearance or turbidity for a
prolonged period.
These various possibilities are summarized schematically in Figure 3.
3.2.1. Nucleation Versus Inhibition
The interfacial free energy is important in the heterogeneous nucleation of one substance by
another and chemical similarity is important in nucleating amorphous substances. The heterogeneous
nucleation of CaP on surfaces rich in phosphate ester groups is common and can be used to create
specific shapes of the mineral phase, oriented growth of crystals [99] and more complex hierarchical
structures. Examples include hollow shells grown on phospholipid vesicles [100] and templated
growth on DNA molecules [101]. Examples of nucleation of CaP by phosphoproteins are given in
Section 2.3. It is sometimes considered paradoxical that a protein can be a nucleator of CaP in one
circumstance and an inhibitor in another (see Section 2.3 and Figure 3). However, facilitated nucleation
at a low molar ratio of phosphoprotein to CaP or complete sequestration at a higher ratio could be
essentially similar processes producing either a mineral phase by nucleation or metastable complexes
or stable complexes as the ratio increases.
3.2.2. Kinetic Stability of Complexes in Metastable Solutions
This topic is the subject of very many publications and to do it justice requires a review of its
own. Reference is made to some of the cited literature in the comprehensive reviews mentioned at
the beginning of this article, particularly [1,2,8–11]. We briefly mention here only a few of the most
salient points.
In general, kinetic stability giving rise to a lag phase during precipitation can arise from the
electrostatic, entropic, or enthalpic interactions of adsorbed polymers. In colloid science entropic
or enthalpic repulsion between dispersed phases is often called steric stabilization and is a highly
effective means of preventing the agglomeration of otherwise unstable colloidal particle [102]. In the
science of IDPs, a similar effect giving rise to repulsion between hydrophilic proteins is described
as due to entropic chains [103]. More specifically, the extent of stabilization, as measured by time
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spent in the lag phase, is influenced by the degree of coverage and conformation of the adsorbed
protein, the dynamics of adsorption, and the strength of binding determined by acidic sequences such
Asp- or Glu- or pSer-rich SLiMs. In addition, the time spent in the lag phase can be determined by
maturation of the ACP and hence is affected by selective adsorption of the protein to specific growth
sites or developing crystal planes and the consequential effect on the rate of conversion of the initial
ACP into more crystalline phases [49,71,104–109]. In this review, we stress that it is not the absolute
concentration of protein that determines the stability of the lag phase but the affinity and concentration
of binding proteins in relation to the concentration of CaP formed by the supersaturated solution
(Figure 3a,b). In a metastable solution in the lag phase, the CaP in the form of kinetically stabilized
complexes is said to be in a state of arrested precipitation.
3.2.3. Thermodynamically Stable Complexes
When the first CaP nanocluster complexes were prepared in the laboratory at milk-like
concentrations of salts and CaP-SLiMs, it was presumed that the CaP in the core of the complex
was in a state of arrested precipitation [18,110,111]. Experimental evidence accumulated, however,
to show that the solutions were thermodynamically stable. For example, any initial turbidity in
the solutions disappeared on storage of the solutions for several days rather than growing into a
precipitate. Moreover, the solutions were remarkable stable. They could be stored at room temperature
for years without apparent change, they could be frozen and thawed, steam sterilized and dried
and reconstituted. Most convincingly, it was found that the nanocluster complexes could be formed
by a “forward” reaction from a supersaturated solution containing a large enough concentration of
competent phosphopeptides and by a “back” reaction by adding the competent phosphopeptide
to a pre-formed, fresh, precipitate of ACP [112]. The “back” reaction is slower than the “forward”
reaction and thereby less practicable. If the ACP matures before adding the phosphopeptide or if
phosphopeptide is used to attempt to disperse a poorly crystalline CaP, the dispersion reaction does
not occur. The conclusion from these experiments is that the sequestered nanocluster solution can
be thought of as existing in a local free energy minimum with an activation free energy sufficiently
high to prevent it from phase separating into a saturated solution at equilibrium with a more stable
crystalline phase of CaP. The position and depth of the minimum are clearly important in determining
the stability of the equilibrium complexes or the lag time of a metastable solution, and the partition of
salts between the complexes and continuous phase.
We envisage (Figure 3) that CaP complexes with phosphoproteins can undergo a reversible
transition between kinetically or thermodynamically stabilized states, depending on the concentration
of sequestering phosphopeptide, its degree and pattern of phosphorylation, and other conditions in the
solution, such as pH. To reiterate, the condition required to form a thermodynamically stable complex
with a competent phosphopeptide, requires an excess of the phosphopeptide to be in the continuous
phase after the complexes have formed. This condition is explained further and made quantitative
in Section 3.5 and summarized in Figure 3. It is important to emphasize that the mechanism of
stabilizing biofluids by forming the equilibrium CaP nanocluster complexes is applicable at µM or
lower concentrations of phosphoproteins, as found in blood serum, the extracellular matrix, or other
biofluids as well as the mM concentrations in milk. Moreover, any of the phosphorylated proteins
listed in Table 1 are capable, at least in principle, of forming the equilibrium complexes provided they
have a high enough affinity for CaP at their physiological concentration.
3.2.4. Destabilization of Thermodynamically Stable Solutions
Destabilization of a supersaturated biofluid containing complexed forms of ACP can occur if
is brought into contact with a more stable crystalline phase of CaP or if there is not enough of the
stabilizing protein or polymer to sequester the CaP formed by the biofluid. Section 3.7 shows how
thermodynamically stable or unstable regions can be defined, depending on pH.
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In both the thermodynamically stable and unstable regions, the continuous phase is supersaturated
with respect to HA, but nucleation is suppressed by an excess of the sequestering phosphopeptide.
In Section 3.5 expressions are given showing how the size of the equilibrium CaP nanocluster
complexes depends on the affinity and concentration of the sequestering phosphopeptides. In Section 4
a calculation is given to show that as the concentration of free sequestering phosphopeptide decreases
towards zero, the size of the complexes increases towards infinity. In other words, precipitation of CaP
occurs. In Section 5.6, these ideas are used to explain how, in biomimetic mineralization experiments
using stable or metastable CaP complexes, intrafibrillar mineralization of collagen fibers can occur
while extrafibrillar mineralization is suppressed.
When a poised solution in the lag phase, or a thermodynamically stable solution of the
equilibrium nanocluster complexes, is brought into contact with a thermodynamically more stable
crystalline phase, the ACP in both types of mineral-protein complexes will tend to undergo the same
solution-mediated solid-to-solid transformation that ACP undergoes in the presence of crystalline
CaP [113]. This theoretically predicted transfer of ions from CaP nanoclusters to hydroxyapatite has
been demonstrated experimentally using native casein micelles [113].
3.3. Ion Activity Product in the Continuous Phase of Solutions Containing Calcium Phosphate
Nanocluster Complexes
It is possible to apply equilibrium thermodynamics to a metastable supersaturated solution in
a prolonged lag phase [83,84] in order to define an effective solubility product, applicable to any
supersaturated solution provided it is well away from the spinodal boundary where no lag phase can
exist [114]. We justify the approach because the time needed for ions to reach equilibrium with the
continuous phase is likely to be short compared to the time spent in the lag phase and we restrict our
application to nearly stable solutions with lag times of days or longer. Likewise, we can use equilibrium
thermodynamics to define the solubility product of CaP nanocluster complexes formed by competent
sequestering phosphopeptides. The solubility products are analogous to those formed by a bulk phase
of CaP in equilibrium with a saturated solution. The CaP nanoclusters are not a bulk phase but typically
contain several hundred CaP molecules, considerably larger than pre-nucleation clusters formed in the
earliest stages of precipitation in a non-classical nucleation mechanism [115–117]. Thus, the form and
magnitude of the solubility constant can depend on the nature of the sequestering phosphopeptide.
Urine has been described as an equilibrium single-phase fluid and as a supersaturated system poised
on the brink of phase separation [118–120] but in both descriptions, an effective solubility constant
describes the partition of salts between the continuous phase and either a bulk phase or complexed
forms of CaP.
Using a generic empirical chemical formula for a phase, containing both HPO2−4 and PO
3−
4 [82],
the equilibrium can be written as.
Ca2+ + yHPO2−4 +
2(1− y)
3
PO3−4 ↔
[
Ca(HPO 4)y(PO 4) 2(1−y)
3
]
solid
(1)
The corresponding ion activity product is {Ca2+}> {HPO2−4 >}
y
> {PO3−4 >}
2(1−y)/3
. If the solid is
stable or metastable for long enough to reach equilibrium with the continuous phase, the ion activity
product can be treated as an invariant thermodynamic property of the system with the same value,
irrespective of the activities of the individual ions. Conversely, if the composition of the solid phase
is unknown, the determination of the invariant ion activity product gives the value y, the effective
solubility of the CaP (KS) and its Ca/Pi ratio, 3/(2 + y). For example, a basic tricalcium phosphate has y
= 0, the ACP-1 and ACP-2 phases of Christoffersen et al. [83] have y = 0.22 and an acidic dicalcium
phosphate has y = 1.0.
The ion activity products of CaP salts of samples of bovine milk and the human biofluids blood
serum and stimulated saliva have been calculated [13] and are shown in Figure 4 [13,121–124]. Results
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were expressed as a saturation index, SI, by dividing the ion activity product by the corresponding
thermodynamic solubility product and are plotted as log(SI) versus sample pH (Figure 4). Thus,
undersaturated, saturated, and supersaturated biofluids have log(SI) values that are negative, zero,
or positive, respectively, and a set of log(SI) values that are consistently close to zero and show no
dependence on pH allows the empirical chemical formula of the CaP substance to be deduced.
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Although there is considerable variation in the composition of each set of samples, the three
biofluids all exhibit an invariant ion activity product, consistent with an equilibrium distribution of
calcium and phosphate ions between the continuous phase and sequestered CaP nanoclusters. Indeed,
for milk the evidence of such an equilibrium is abundant and compelling through the existence of
CaP nanoclusters in casein micelles as determined by chemical analysis and a range of structural
methods [39,127,129–135].
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3.4. Calculation of the Partition of Salts in a Biofluid Containing CaP Nanocluster Complexes
The CaP nanocluster complex Ak,m of concentration ak,m comprises k molecules of CaP and m
bound phosphopeptides. Concentrations are expressed as mole fractions, i.e., the number of moles of a
component divided by the sum of the number of moles of all components in the solution. Standard
states are therefore for the pure substances. The total mole fraction of the peptide is atotal and the mole
fractions of bound and free peptides are abound and afree, respectively, so
atotal = abound + a f ree =
∞∑
m=1
∞∑
k=1
mak,m + a0,1
Nanoclusters Serum
(2)
where a0,1 is the mole fraction of free phosphopeptide. Likewise, a1,0 is the mole fraction of single
CaP molecules in the solution. An equation corresponding to Equation (2) can be written for the total
concentration of CaP molecules, atotalCaP
atotalCaP = a
bound
CaP + a
f ree
CaP =
∞∑
m=1
∞∑
k=1
kak,m + a1,0
Nanoclusters Serum
(3)
where aboundCaP and a
f ree
CaP are concentrations of CaP molecules in the CaP nanoclusters and continuous
phase, respectively.
Partition is typically achieved by means of ultrafiltration through a membrane with a molar mass
cut-off of 10,000 Da to separate the nanocluster complexes and free sequestering peptide from the
serum or continuous phase. A thermodynamic model of the biofluid is used to calculate the equilibria
among the principal small ions in the continuous phase such as Ca2+, HPO2−4 and CaHPO4 but it needs
to be recognized that biofluids are usually more complex than the model because of a plethora of minor
ions and other constituents. The model also assumes that all components in the continuous phase are
in the form of simple ions and ion complexes and that the concentrations of pre-nucleation clusters
are small compared to other free ions and ion pairs in the model (for references see [13]). A tractable
theory of the additional calculation of the partition of salts between sequestered and free forms in a
physiological fluid containing phosphopeptides can be formulated on the assumption that there is a
further equilibrium reaction in which phosphopeptides bind strongly to ACP to form a distribution
of complexes.
An estimate of the composition of the CaP nanocluster complex is obtained by subtracting
the ultrafiltrate from the total concentrations. If there is a significant concentration of excess free
sequestering peptide then it is also necessary to know its concentration and ion binding properties.
Limited experimental evidence over a restricted range of a few compositional variables shows that the
sequestered nanocluster complexes have a nearly constant composition and size, and that the serum
exhibits an invariant ion activity product [24,112].
Application of the model to simple nanocluster complexes made with single short acidic peptides,
and to milk and some other biofluids has been described [13,24,112,128]. An improved calculation
procedure called Model 2 has allowed a more detailed description of the partition of the individual
caseins [39].
3.5. Thermodynamic Description of the Formation of CaP Nanoclusters Sequestered by Short
Acidic Phosphopeptides
In this Section an expression is derived for the size distribution of the nanocluster complexes
formed with short acidic phosphopeptides. The complexes have no tendency to associate with
themselves and form larger structures such as the casein micelles of milk. Thus, they comprise a core
of the CaP nanocluster surrounded by a sequestering shell of bound peptides. A simple balance of the
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free energy of forming the core against the free energy of sequestration gives the following expression
for the equilibrium radius of the core.
rcore =
2VACP∆G∗shell/A
−∆G∗CaP
(4)
where ∆G∗shell/A is the standard free energy of forming the shell of sequestering phosphopeptides
per unit area of core surface, ∆G∗CaP is the standard free energy of forming the core of CaP and VCaP
is the molar volume of the CaP [24]. Equation (4) is very similar to the expression for the size of a
critical droplet in the capillary theory of nucleation originally formulated by Volmer [136] but with the
important difference that ∆G∗shell is negative and ∆G
∗
CaP is positive. In qualitative terms, the formation
of the complexes is driven by the negative free energy of sequestration to the extent that the formation
of the core occurs from a solution formally undersaturated with respect to a bulk phase of the core CaP.
The implications of this analysis for the stability of biofluids that contain the nanocluster complexes are
profound. We have also used the equilibrium thermodynamics of associated solutions [137] to derive
expressions for the free energy of forming the CaP nanocluster in an ideal solution [24]. A distribution
law was derived for the core size of single nanocluster particles stabilized by either short casein
phosphopeptides or the larger N-terminal half of OPN. The treatment assumed that the complex was
formed by association of “monomers” of a single peptide with a proportion of the CaP already bound
to them. Here we summarize a modified treatment [138] that starts from separate molecules of CaP
and sequestering peptides to bring out the effect of the peptide concentration explicitly.
The free energy of formation of the complex is formally divided into two processes. This is a
formal exercise to derive the overall free energy change and is not a description of the sequence of
events or mechanism of forming the complexes. The first process is formation of the core by successive
additions of single molecules of CaP, A1,0
A1,0 + Ak−1,0  Ak,0 (5)
The standard free energy change for the formation of the k-mer from k monomers is
∆G∗k = µ
∗
k,0 − kµ∗1,0 = k∆G∗CaP (6)
where ∆G∗CaP is the free energy of forming a pure phase of the nanocluster core CaP, µ
∗
0,1 and µ
∗
k,0
are the standard chemical potentials of the monomer and k-mer, respectively. This phase, in contact
with solvent, forms a saturated solution containing a mole fraction a1,0,sat of CaP molecules so that
∆G∗CaP = RT ln a1,0,sat.
In the second formal process, m molecules of free peptide sequester the CaP k-mer within a shell
of m peptides
Ak,0 + mA0,1  Ak,m (7)
If VCaP is the volume of a CaP molecule then the number of sequestering peptide molecules, m is
given by
m = sCaPk2/3 (8)
where
sCaP = (36piV2CaP/A
3
CaP)
1/3
θseqk2/3 (9)
θseq is the fraction of total binding sites occupied by the peptides. The standard free energy change of
this reaction is
∆G∗shell = µ
∗
k,m −mµ∗0,1 − µ∗k,0 (10)
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The standard free energy of forming the shell is formally equivalent to the standard free energy of
sequestration by m molecules of the phosphoprotein
∆G∗shell = m∆G
∗
seq (11)
For equal and independent binding sites on the surface of the CaP,
θseq = Kseqa0,1/(1 + Kseqa0,1) (12)
where ∆G∗seq = −RT ln Kseq. The free energy of forming the complex becomes
∆Gk,m = sCaPk2/3∆G∗seq + RT ln
 a
k
1,0,satak,m
ak1,0a
sCaPk2/3
0,1
 (13)
Hence, at equilibrium, the distribution of chemical species becomes
ak,m = a
sCaPk2/3
0,1 S
k exp
− sCaPk2/3∆G∗seqRT
 (14)
where the saturation ratio is defined as S = a1,0/a1,0,sat so that a thermodynamically stable solution has
S ≤ 1. The normalized number fraction distribution of complexes, N(k), can be generated from Equation
(14) by multiplication of the function by a constant C′, such that 1 = C′
∞∑
k=1
ak,m. The normalized
distribution has a peak at
k′ =
[−2sCaP ln(Kseqa0,1)
3 ln S
]3
(15)
In a solution containing a competent phosphopeptide and certain concentrations of calcium and
phosphate ions, the CaP nanoclusters form spontaneously (k > 1) if S < 1, and Kseqa0,1 > 1. In other
words, a biofluid containing nanocluster complexes is at equilibrium below the saturation level for the
bulk phase of CaP; the solution cannot precipitate pure CaP if this condition is met. The minimum
concentration of free sequestering peptide in a stable biofluid, a0,1,min, is specified by a0,1,min = K−1seq.
Thus, a higher affinity of the peptide for the core CaP, means a lower minimum concentration of free
peptide. There is no maximum concentration of free peptide as this is determined by the concentration
of CaP that might form in the biofluid. Indeed, an arbitrarily large number of nanocluster complexes
may be present in the biofluid without it becoming unstable. This property is exploited in forming
milk and may apply to extracellular fluid near the mineralization front of hard tissues. For a given
biofluid composition the total peptide concentration required for stability varies with pH as shown in
a biofluid stability diagram (as described in Section 3.7).
3.6. Evaluation of the Number Fraction Distribution
The position and shape of N(k) depends on the saturation, S and the product Kseqa0,1. Numerical
evaluation of the normalized distribution function shows that at a given value of k′, the distribution
becomes narrower and S decreases as Kseqa0,1 increases. At a given constant value for k′, the breadth of
the distribution decreases as Kseqa0,1 increases, as shown in Figure 5.
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Figure 5. Three e le size distribution curves of nanocluster complexes where the radius of the peak
of the distribution was held constant and the product Kseqa0,1 was either 1.05, 3.65 or 10.0 in curves
1, 2, and 3, respectively. Parameters that were kept constant were, ACaP = 1.7 nm2, VCaP = 0.12 nm3,
empirical chemical formula of the CaP: Ca(HPO4)0.4(PO4)0.4. The lower bound of the distributions, as
clearly shown in curve 1 is the radius of the core formed from a single molecule of CaP (k = 1). Curve 2
is a narrow distribution that describes the size distribution of CaP nanoclusters sequestered by β-casein
1–25, as discussed in Section 4.1.
3.7. Stability of Biofluids and the Facile Co-Existence of Soft and Mineralized Tissues
Certain biofluids such as saliva have a role in the remineralization of a hard tissue, in this case
the tooth, but ectopic deposition of CaP on other surfaces such as gums must be limited or reversible.
In principle, a solution containing nanocluster complexes can satisfy both requirements [139]. In contact
with soft tissue, the biofluid is stable, even though it is supersaturated with respect to crystalline CaPs,
because it is undersaturated with respect to the first-formed amorphous form of CaP. In contact with a
hard tissue such as a tooth, however, a solution-mediated transfer of calcium and phosphate ions from
the continuous phase of the biofluid to the tooth mineral is thermodynamically favorable and was
observed experimentally when casein stabilized CaP nanoclusters were equilibrated with HA [113].
Although a biofluid may be stable under conditions of homeostasis, a destabilizing fluctuation in
its composition may render the biofluid unstable and prone to form ectopic CaP deposits. A measure
of how resistant a biofluid is to destabilizing fluctuations is provided by the biofluid stability diagram.
The minimum concentration of CaP-SLiMs needed to sequester the quantity of CaP formed at
equilibrium in response to a change of composition can be calculated from the condition Kseqa0,1 ≥ 1 if
Kseq is known, otherwise an approximation is to find the stoichiometric concentration of sequestering
peptide required to react with the CaP nanoclusters assuming they have a constant size and composition.
This latter criterion has been used as a function of pH to calculate the stability diagram for a variety of
biofluids [13,39]. An example of the stability diagram for an average bovine milk is shown in Figure 6.
The stability diagram defines areas of stability and instability. Below a certain pH, called the
critical pH, pHc, no phosphopeptides are needed to make the biofluid stable. If the physiological pH
is above the critical pH, it will be liable to nucleate CaP. Nevertheless, if it contains a high enough
concentration of a sequestering phosphopeptide it can be perfectly stable, even at the physiological pH,
but at equilibrium it will then contain nanoclusters of sequestered CaP. For the example calculation
shown in Figure 6, the physiological pH is about 6.7 where the minimum concentration of CaP-SLiMs
needed for stability is about 900 µM. About 80–90% of the CaP-SLiMs on caseins are required to
sequester CaP and the remainder are available to buffer the effect of an increase in pH. Bovine milk is
well buffered to cope with the loss of CO2 and hence small increase of pH when it is exposed to air but
human milk is not and an increase of 0.2 pH units or more can occur [140].
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As pH increases, the minimum concentration of CaP-SLiMs, Cmin, increases in a curvilinear
manner up to a plateau value, Cmax, typically above pH 8. Close to the boundary line, on the higher pH
side, is an ill-defined area of metastability where precipitation may be delayed for some time in a lag
phase. Farther to the right of the thermodynamic stability curve (i.e., at higher pH), beyond the region
identified as metastable, lies the spinodal boundary. This marks the practical limit of metastability for
a single-phase system. Experiments to determine the position of the spinodal in a milk-like casein-CaP
system have not been reported, but the approximate position of the spinodal in an artificial blood
system using an osteopontin phosphopeptide mixture as the sequestrant has been described [13].
It is apparently paradoxical that the saturation index of blood serum should be so similar to that
of a solution of OPN nanocluster complexes whereas circulating levels of OPN are seemingly low
compared to the major blood phosphoprotein, fetuin A [17,141].
A simple analytical expression to describe the stability diagrams is desirable. The stability diagram
of milk and some other biofluids [13] is similar in shape to a binding isotherm and can be fitted nicely
by a type of Hill equation [142] using a non-linear least squares method. The equation can be written as
Cmax/Cmin = 1 + exp
[
n ln
(pH1/2 − pHc
pH− pHc
)]
(16)
Where the dependent variable on the ordinate is Cmin and the independent variable on the abscissa
is pH. The fitted parameter pH1/2 is the pH value at which Cmin/Cmax = 1/2 and n is a fitted shape
parameter. In the original Hill equation n described the co-operativity of binding oxygen molecules to
molecules of hemoglobin but it has no direct physical meaning here.
The stability diagram of a reference bulk milk is shown in Figure 6 and fitted curves for milk
samples from 18 individual cows have been reported [39]. Considerable variation was found in the
stability diagrams of the individual milk samples. Half were stable to any change of pH and 16 were
stable at or above the natural pH but two were slightly metastable at their natural pH. Three of these
examples are shown in Figure 7. All three individual milk samples have a similar total concentration
of CaP-SLiMs, a little over 1.6 mM but the corresponding stability curves are very different because of
Crystals 2020, 10, 755 18 of 45
differences in salt composition. Thus, sample PM04 is stable to pH variation, sample JL09 is stable up
to pH 7.4 but JL01 is unstable even at its physiological pH.
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4. Properties of Some Calcium Phosphate Nanocluster Complexes
Historically, the scientific study of nanocluster complexes began with the characterization
of the native substructures of the casein micelles in milk, known then as colloidal [143,144] or
micellar [145] CaP, which established that the CaP occurred as amorphous particles with a size of
several nm [91,146,147]. Attempts to isolate the CaP from its casein matrix always co-extracted tightly
bound peptides corresponding to the most highly phosphorylated casein sequences [148]. Further
understanding of the nature of the nanocluster complexes came from model studies using single pure
casein, OPN, and recombinant phosphopeptides. Major achievements of the work on the artificial
nanocluster complexes were the successful calculation from basic principles of the partition of salts
between casein micelles and the continuous phase [39,128] and precise prediction of the scale of the
substructure of casein micelles from the core molecular mass [149]. In the early work on artificial
nanocluster complexes [18,110,111], it was believed that the complexes were metastable, i.e., in an
arrested state of precipitation, and so a special technique was developed to make the preparation of
artificial nanocluster complexes as reproducible as possible. The peptide and salts were mixed at a low
pH where the solution was undersaturated and the pH was raised homogeneously and in a controlled
manner by hydrolyzing urea with the enzyme urease to release the strong base ammonia. Subsequently
it was shown [112] that the complexes were equilibrium structures and that even an initial precipitate,
if formed during mixing, would dissolve if sufficient time was allowed for the system to equilibrate.
Several commercial applications have been found for casein phosphopeptides prepared on a large
scale by chromatography or precipitation methods [150]. CaP nanoclusters sequestered by a mixture
of bovine casein phosphopeptides have been used in dental products to promote the remineralization
of demineralized tooth lesions [151].
4.1. Size and Structure of Calcium Phosphate Nanoclusters Sequestered by β-Casein 1–25
The first artificial CaP nanocluster complex to be prepared used the N-terminal tryptic
phosphopeptide, β-casein 1–25 [18,110]. It remains the only one for which a precise molar mass
has been determined [111]. Using a combination of small-angle neutron scattering with contrast
matching and approach-to-equilibrium analytical ultracentrifugation, the weight average core and
shell masses and root mean square Z-average core radius were 6·104 Da, 1.37·105 Da and 2.4 nm,
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respectively [111]. These properties are consistent with a narrow normalized distribution of core-shell
particles (Equation (14)) with a peak at k′ = 436, Kseqa0,1 = 3.65, S = 0.94 and θseq = 0.785, as shown
in Figure 8 using the parameters of Table 2. The example distribution has a narrow dispersion,
as measured by the ratio k
2
/
(
k
)2 − 1 = 0.0988 where the bar over the k or k2 indicates a number average.
The core surface area per peptide was 1.7 nm2, which is comparable to the area per statherin peptide
in a monolayer adsorbed onto HA [55]. The relatively small area per peptide indicates that only a
fraction of the peptide is in contact with the core surface, as in example A of Figure 2. The contact
sequence is most likely the acidic CaP-SLiM (Table 1) 14-EpSLpSpSpSEE-21 in the middle, least mobile,
region of the peptide [110,152]. The other parameters used in the calculation were the molecular
volume of the CaP calculated from its empirical chemical formula, as determined from the form of
an ion activity product in the nanocluster solution to be Ca(HPO4)0.4(PO4)0.4. Other distribution
functions that gave reasonable agreement with the average radius of the core were also narrow with
Kseqa0,1 > 3.65, S < 0.94 and θseq > 0.785.
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It was observed experimentally that the initial size of the nanocluster complexes depended on
the rate at which the pH was raised by the urea/urease reaction but after equilibration for 24–48 h,
the average size of nanocluster complexes was constant and relatively insensitive to the temperature,
pH and concentrations of phosphopeptide, Mg and citrate in the solution from which they were
formed [112]. The present calculations show that this is expected for the concentrations of salts and
peptide used in experiments where there is an excess of strongly binding phosphopeptide which gives
rise to a narrow, and almost invariant, particle size distribution (Figure 8).
The nanocluster complexes have been characterized by a variety of nuclear magnetic resonance
methods [110,152]. Using an isotropic diffusion model for methyl resonances, the diffusion radius of
the particles was in the range 1.6 to 1.9 nm, depending on pH [152], significantly but not dramatically
smaller than indicated by scattering measurements. In an earlier study [110] it was found that not
all residues had the same mobility. A proportion of the N- and C-terminal Arg residues were as
mobile in the complexes as in the free peptide, but complexation greatly reduced the mobility of the
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phosphorylated residues. The size and structure of the complexes was also studied by small-angle
X-ray scattering (SAXS) [112]. In the Guinier region, the radius of gyration was found to be constant at
2.55 ± 0.08 nm between pH 6 and 8 but the intensity of scattered X-rays increased with pH and reversed
fully on acidification. Likewise, the radius of gyration was constant in the measured temperature
range of 5 to 80 ◦C. The intensity of scattered X-rays increased with temperature but reversed fully on
cooling. In a determination of the specific heat change on heating and cooling by differential scanning
calorimetry, a reversible but smooth increase with temperature was noted without any indication of a
sharp transition such as might be caused by a conformational change in the peptide shell or a phase
change in the CaP core. These three demonstrations of the reversibility of CaP nanocluster formation
are due to an increase in the number of the particles in the solution with increase of temperature or pH
while the particles remain essentially constant in average size and, therefore, in average composition.
The constant composition assumption is used in the calculation of salt partition in CaP nanocluster
solutions, including milk [39,112,128].
Table 2. Comparison of experimental average values of the core and shell weight average molar masses
and the core root mean square radius [111] with calculated values from a theoretical distribution
calculated from Equation (14).
Parameter Experiment Parameter Calculation
Empirical volume CaP, nm3 0.167 0.12
Surface area per peptide, nm2 1.62 1.7
Mw(CaP core) 10−4 Da 6.0 6.0
Mw(peptide shell) 10−5 Da 1.37 1.37〈
r2core
〉1/2
z
, nm 2.44 2.44
Empirical formula CaP Ca(HPO4)0.4(PO4)0.4 Kseqa1,0 3.65
pKS 8.0 S = a0,1/a0,1,sat 0.940
θseq 0.785
Modal k′ 436
kn ± SD 468 ± 147
k
2
n/(kn)
2 − 1 0.099
In addition to these observations demonstrating the reversibility of the system, it was found
that the CaP nanocluster complex solution could be stored at room temperature for months or years
without visible change. They can even withstand steam sterilization or freezing and thawing due to
the stabilizing effect of the phosphopeptide.
The reversibility of the properties of solutions containing nanocluster complexes is similar to
the reversibility in the partition of milk salts with pH and temperature [153–155]. Indeed, when CaP
nanocluster solutions are prepared with similar total concentrations of salts and CaP-SLiM-containing
peptides to those in milk, the partition of salts in the two types of solution are strikingly similar when
compared at the same temperature and pH [110,112,128].
4.2. Structure and Dynamics of a Calcium Phosphate Nanocluster Sequestered by OPN 1–149
OPN has a multitude of in vivo functions [17], including various roles in the complex process
of biomineralization [156–160]. The precise function of OPN within the various processes related
to biomineralization is heavily influenced by its state of phosphorylation. Phosphoforms of OPN
have been shown to slow or inhibit the precipitation of CaP [24,76,105,161,162] but unphosphorylated
OPN has a much weaker effect. The presence of OPN in most biological fluids combined with its
intrinsically disordered conformation [24,27,62,163,164], ability to influence the precipitation of CaP
and the presence of multiple CaP-SLiMs, suggests a possible general, in vivo, role for OPN in stabilizing
biofluids through the sequestration of CaP.
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Highly phosphorylated OPN peptides (OPNmix) are abundant in bovine milk [165]. The larger
OPN fragments isolated from OPNmix by gel filtration chromatography consists mainly of N-terminal
peptides which vary in length from 145–156 residues, formed through proteolytic cleavage of the mature
sequence [166]. Due to the small differences in length and difficulty in further separation, these peptides
were grouped together and referred to as OPN 1–149 [24]. Three multiply phosphorylated CaP-SLiMs
can be identified within the N-terminal region [24,167], two of which are shown in Table 1. Various
experimental studies have reported on the ability of OPN 1–149 to sequester CaP resulting in the
formation of metastable [168] or equilibrium nanocluster complexes [13,24,62,169], depending on
solution conditions and the molar ratio of OPN to CaP.
The nanocluster complexes stabilized by OPN 1–149 are significantly larger, on average, than those
formed by β-casein 1–25 (Figure 9). The outer shell radius and thickness are consistent with a single
layer of OPN 1–149 but folded so that all three of the CaP-SLiMs bind to the core [24,62]. This is
in contrast to the structure of the CaP nanoclusters stabilized by β-casein 1–25 or αS1-casein 59–79
where the outer shell comprises a layer of protein interacting through a single CaP-SLiM [111,112].
However, the radius of gyration of the CaP nanocluster sequestered by the recombinant phosphopeptide
CK2-S-6H (Section 4.3) is also consistent with a surface loop conformation [40]. The core radius of the
CaP nanocluster formed by OPN 1–149 is about 4 times larger than that of the complex formed by
β-casein 1–25. According to Equation (4), the size of the core is dependent on the ratio of the free energy
of sequestration per unit of core area to the free energy of formation of the bulk core phase [24,139].
The CaP core of OPN 1–149 complexes is more basic than in casein nanocluster complexes (y = 0 in
Equation (1)), although with similar molar ratios of Ca and Pi to CaP-SLiM. The conclusion was that
the core of the OPN 1–149 complex was more highly hydrated or contained more void spaces than the
CaP nanocluster complex formed with β-casein 1–25. Neutron diffraction of hydrated samples using
contrast matching of protein showed that the core CaP was amorphous [170]. Previous determinations
of the amorphous nature of the CaP core had all used freeze-dried samples which might have lost
crystalline order through the removal of water [91,145,146].
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149 (a) and β-casein 1–25 (b). The illustration shows the core-shell substructure by removing a
one eight segment of the shell. Z-average core radii are 12.5 and 2.4 nm and shell thicknesses 1.5 and
1.6 nm for the OPN 1–149 and β-casein 1–25 complexes, respectiv ly [24,111].
Neutron scattering has been used to quantify the dynamic properties of OPN 1–149 and its CaP
nanocluster complex at nanosecond-Ångström resolution. Using elastic incoherent neutron scattering
it was found that the molecular fluctuations of the free phosphopeptide were similar to those of other
IDPs [62]. When complexed to the CaP nanoclusters, however, there was increased resilience of the
diffusive motions. The molecular fluctuations became more like those of a typical globular protein.
Studies of the effect of phosphorylation on the dynamic properties of a similar recombinant human
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OPN1–156 peptide were made by quasi-elastic neutron scattering experiments. These confirmed that
the protein was highly dynamic compared to globular proteins. When a phosphorylated form of
human OPN1–156 was studied [163] it was found that phosphorylation blocked some nanosecond side
chain motions while increasing the flexibility of others on the faster timescale. The combined results
from the dynamic measurements agree in showing that the free bovine and human sequences are
highly flexible. It is suggested that the flexibility allows phosphoforms of OPN to rapidly react with
growing nuclei of CaP and form a compact shell of protein around the CaP core. The sequestration
of the CaP nanoclusters therefore reduced the flexibility of the protein significantly because of steric
restriction and, possibly, because all three CaP-SLiMs in the sequence bind to the surface of the core.
The ability of OPN 1–149 to sequester ACP and stabilize CaP nanoclusters shows that
CaP-SLiM-containing IDPs other than those belonging to the casein family of proteins can stabilize
solutions of CaP. The sequestration of CaP nanoclusters by phosphorylated IDPs may therefore be of
general physiological importance. It also reveals something about the specific influence of the chain
length and sequence on the properties of the formed nanocluster complexes.
4.3. Structures of Calcium Phosphate Nanoclusters Sequestered by Other Phosphopeptides or Mixtures
of Phosphopeptides
Nanocluster complexes have been prepared from a range of other phosphoproteins to study
the effects of sequence variation on their composition, size, and structure. These included a tryptic
phosphopeptide, residues 59–79 from αS1-casein, [112,171], tryptic phosphopeptides 1–42 and 2–25
from β-casein [111], mixtures of phosphopeptides derived from either whole casein [112,172] or bovine
milk OPN (OPNmix) [13,62,150,163,170] and several different recombinant phosphopeptides. The latter
were expressed as phosphoforms by a double plasmid transformation of E. coli. A high copy number
plasmid expressed the desired peptide while a low copy number plasmid was used to co-express
the catalytic subunit of casein kinase II (CK2) [40,163]. Sequences of some of these sequestering
phosphopeptides are given in Table 3.
Table 3. Sequences of tryptic phosphopeptides from bovine β- and αS1-caseins, two recombinant,
tryptic phosphopeptides, based on β-casein (CK2-S and CK2-SS) and a soluble whole construct based
on the N-terminal region of β-casein with a C-terminal 6-His tag (CK2-S-6H) [40,112]. Phosphorylated
residues are shown in boldface red.
Phosphopeptide Sequence
αS1-casein B 59–79 4P QMEAESISSSEEIVPNSVEQK
β-casein A2 1–25 4P RELEELNVPGEIVESLSSSEESITR
CK2-S 4P MRELEELNVPGADDSSSDDDSDDDDRINKK
CK2-SS 4P MRELEELNVPGADDSSSSDDDDDDDRINKK
CK2-S-6H 5P MRELEELNVPGADDSSSDDDSDDDDRINKKIEDPNSSSVDKLAAALEHHHHHH
Bovine αS1-casein 59–79 is a highly acidic phosphopeptide, similar to β-casein 1–25, with a
single CaP-SLiM containing four phosphoseryl residues. The nanocluster complexes prepared using
this peptide [112] are somewhat similar in size to those formed with β-casein 1–25. The Z-average
radius of gyration determined by SAXS in the Guinier region was 2.23 ± 0.05 nm and was essentially
independent of pH in the range 6 to 8. The composition of phosphopeptide mixtures derived from
whole casein is complex and variable according to the commercial source and preparation and or
purification methods. Nevertheless, they contain a proportion of less highly phosphorylated peptides.
Hence, in the preparation of the nanocluster complexes a concentration of 10 mg ml−1 of the casein
phosphopeptide mixture was used, rather than the standard 5 mg ml−1 employed with the pure
phosphopeptides. The nanocluster complexes formed with the mixture of phosphopeptides were,
on average, somewhat larger and the average radius of gyration determined by SAXS passed through a
shallow minimum in the pH range 6 to 8 rather than being constant [112]. Nevertheless, an invariant ion
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activity product was found over this pH range for the empirical chemical formula Ca(HPO4)0.6(PO4)0.27
with pKS = 7.8, similar to the composition and solubility found in milk [12]. In contrast, an apparently
similar study [172] reported that the complexes contained a basic CaP.
Protein engineering of recombinant peptides made possible a more systematic study of the
structural requirements of CaP sequestration [40]. Most work was done with constructs comprising one
or more tandem repeats encoding a sequence based on the bovine β-casein 1–25 peptide. The sequences
were modified for (i) efficient overexpression in E. coli. (ii) phosphorylation by the α-catalytic subunit
of casein kinase II and (iii) rapid purification by means of a C-terminal 6-His-tag. Tandem repeats
were separated by tryptic cleavage and further purified. A phosphorylated form of a human OPN-like
peptide was also expressed [40] and studied [163] (see Section 4.2).
Because of its importance to CaP sequestration, particular attention was given to the
characterization of recombinant peptide phosphoforms since it is the norm for kinases to
only partially phosphorylate their substrates [173]. The designed kinase recognition sequences
comprised a stretch of Asp residues on either side of the residues to be phosphorylated such as
13-D-D-S-S-S-D-D-D-S-D-D-D-D-26 in CK2-S (Table 3). Notwithstanding the efforts to obtain a
completely phosphorylated CaP-binding SLiM, the expressed constructs invariably comprised a
mixture of phosphoforms (Figure 10a) with, predominantly, four or five phosphorylated residues,
three or four of which were in the above subsequence. Nevertheless, phosphorylation occurred only at
consensus recognition sites for this kinase. When the expressed phosphoforms were chromatographed
on a HA column (e.g., Figure 10b), the elution volume generally increased with the total number of
phosphorylated residues. Some of the phosphoforms were bound to the column more strongly than
others even if they had the same total number of phosphorylated residues. The evidence from all
the phosphopeptides examined was consistent with the hypothesis that a high-affinity phosphoform
contained a sequence where three phosphorylated residues were close together in the sequence, such as
15-pS-pS-pS-17 in CK2-S. On the other hand, lower affinity phosphoforms had only two of the three
seryl residues in their main cluster converted to phosphoseryl residues (Figure 10c). The inference
from these findings is that the minimum concentration at which a phosphopeptide is effective in CaP
sequestration (i.e., K−1seq) is lower if the phosphopeptide contains three phosphorylated residues in a
subsequence of 3 or 4 consecutive residues. It was similarly reported that in β-casein 1–25, where there
are three consecutive phosphorylated residues, and in similar peptides, there is a single high-affinity
binding site for calcium (Ca2+) or hydronium (H+) ions [37–39].
The ability of three CaP-SLiM-containing recombinant peptides to sequester CaP was determined
by SAXS and further determinations of the radii of gyration were made on high-affinity fractions of two
of the peptides from HA chromatography. The peptides CK2-S and CK2-SS were similar 28-residue
tryptic peptides that formed stable nanocluster complexes with a radius of gyration of 8.85 nm within
about 2 days and a high-affinity fraction of CK2-S formed an equilibrium complex of radius of gyration
9.89 nm. The recombinant peptide CK2-S-6H is 53 residues long, including the CK2-S subsequence
with a C-terminal extension plus a 6His tag. It formed an equilibrium complex over 4–5 days with a
radius of gyration of 7.71 nm. The high-affinity fraction of CK2-S-6H from HA chromatography formed
a CaP nanocluster complex with a radius of gyration of 9.72 nm but equilibration was unusually
slow (Figure 10d). The CK2-S and CK2-SS peptides are similar in length to the β-casein 1–25 and
αS1-casein 59–79 peptides but the nanocluster complexes are more than three times larger pointing to
a larger core radius as the cause. The high-affinity fraction of CK2-S forms an even larger complex,
presumably due to a larger core radius. Nevertheless, the longer CK2-S-6H peptide forms a smaller
complex than its subsequence, CK2-S, indicating that the shell peptide may loop back on itself in the
shell like a multi-dentate ligand (Figure 2B,C). According to Equation (4) the core radius depends on
the ratio of the free energy of sequestration of the shell peptide to the free energy of formation of the
core CaP and on the area per CaP-SLiM. However, charge density in the shell, steric restraints on the
density of packing of peptides in the shell and the hydration and chemical composition of the core
may influence each of these terms. It is desirable that these preliminary observations are followed-up
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with more detailed and systematic studies of the effects of the structure of sequestering peptide on the
substructure, shell and core masses of the nanocluster complexes and the partition of salts and peptide
between the complexes and the continuous phase.
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Figure 10. Phosphoforms of CK2-S-6H and nanocluster complexes formed by the high-affinity
phosphoforms [40]. (a) RP-HPLC of the recombinant purified peptide with numbering corresponding
to the total number of phosphorylated sites. Most phosphoforms have 4 or 5 phosphorylated residues.
Five sites are in consensus kinase recognition sequences (Table 3) and a small proportion were in a
6-P form. (b) Ion exchange chromatography of CK2-S-6H on hydroxyapatite revealed groups of low
and high-affinity phosphoforms, mostly separated by the number of phosphorylated residues but
sensitive also to positional isomers. (c) Schematic rationalization for how the positional isomers of
the 4-P phosphoform can occur as either low or high-affinity isomers. In the diagram, filled black
circles are phosphorylated sites. The isomers with 3 or 4 phosphorylated residues close together form a
high-affinity phosphoform. (d) Results from small-angle X-ray scattering measurements of the radius
of gyration of nanocluster complexes made with the high-affinity fraction of CK2-S-6H showing the
very slow change in the radius of gyration with time for this phosphopeptide.
5. Application to Biofluids
Nearly all physiological fluids are supersaturated with respect to HA and some other crystalline
CaP phases. As a result, artificial biofluids that closely resemble their natural counterparts in salt
composition and pH are unstable and will readily precipitate CaP. They, and natural biofluids, therefore
require stabilizing agents. Of all physiological fluids for which data are available, milk contains the
highest concentration of CaP. The role of the casein SCPPs in stabilizing milk with respect to CaP
precipitation is now well established. Other phosphoproteins are expressed in physiological fluids,
hard and soft tissues, raising the possibility that phosphoproteins with CaP-SLiMs may perform a
similar physiological role to casein in milk. The SCPP OPN is almost universally expressed in chordate
tissues and biofluids [17] and as discussed in Sections 2 and 4.2, has all the key physical and chemical
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characteristics needed for the role. However, phosphoproteins such as fetuin A in blood and others in
Table 1 must also be considered. In the extracellular matrix of mammalian bone, for example, OPN is the
major non-collagenous phosphoprotein, though it is not as highly phosphorylated in bone as in bovine
milk [1]. In saliva, the main inhibitor of CaP precipitation is the SCPP statherin, present at 3–27.3 µM
with some additional effect from the acidic proline-rich salivary peptides [63,174,175]. Notwithstanding
these general principles and suggestive experiments, the direct experimental observation of nanocluster
complexes in any biofluid other than milk has not yet been reported.
The stability diagrams for salt solutions approximating the typical composition of three very
different biofluids, urine, saliva, and blood serum have been calculated, on the assumption that OPN
phosphopeptides are responsible for sequestration, and compared to experiment [13]. Table 4 gives the
fitted parameters.
Table 4. Parameters of Equation (16) required to fit the stability curves of Figure 11.
Biofluid Cmax, mM n pH1/2-pHc pHc
Bovine milk 1977 ± 3.0 1.190 ± 0.003 0.508 ± 0.001 5.716 ± 0.004
Human milk 743 ±1.6 0.914 ± 0.006 1.458 ± 0.583 7.200 ± 0.003
Human blood serum 166 ± 7.6 0.949 ± 0.024 1.240 ± 0.011 7.760 ± 0.002
Human stimulated saliva 133 ± 3.6 1.036 ±0.003 0.468 ± 0.003 6.880 ± 0.002
Human urine 398 ± 5.8 1.075 ± 0.022 0.531 ± 0.015 6.529 ± 0.002
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Bovine milk is well buffered by proteins and phosphate ions and urine by phosphate ions,
but human blood serum, milk, and saliva are, by comparison, poorly buffered. The homeostatic
mechanisms that regulate blood pH do so through the exchange of CO2 with air through the chemical
equilibria CO2+H2O H2CO3  HCO−3 + H
+ . In healthy individuals, blood pH is tightly monitored
within a very narrow range (from about 7.3 to 7.5) by a group of nerve cells located in the medulla
oblongata but regulatory control may be lost in certain conditions to produce more acidic or alkaline
sera. According to the Davenport diagram for typical human blood [176] with a pH of 7.4 at equilibrium
with a partial pressure of CO2 of 40 mm Hg, equilibration with air at a CO2 partial pressure of 17 mm
Hg raises the pH to over 7.7, close to the critical pH in the stability diagram where sequestering
phosphopeptides are needed for stability. If the concentration of CaP-SLiMs is insufficient, calciprotein
particles can form spontaneously [177]. Calciprotein particles have, indeed, been isolated from blood.
These contain fetuin A as the major phosphoprotein component, MGP and SPP-24, among other acidic
serum proteins [142,178–182] and, once formed, are cleared from the circulation by the liver [183].
The stability diagram calculations indicate that although the physiological pH of blood serum and
human urine are slightly below the typical critical pH values of these biofluids, that of saliva (~7.35) is
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above the critical pH and is predicted to contain some sequestered stable or metastable CaP particles.
Human milk is on the borderline, with pH almost equal to pHc. Hence when it equilibrates with air
and loses CO2 [140], the rise in pH appears to be sufficient to form a small concentration of sequestered
CaP nanoclusters in the casein micelles, as observed experimentally [184], though the concentration is
much lower than in bovine milk. The physiological pH of urine is normally well below the critical pH,
at or around pH 6.0 to minimize calcium oxalate stone formation at lower pH and CaP precipitation at
higher pH [185]. The pH of urine is particularly sensitive to the effect of infection by bacteria secreting
an extracellular urease to raise the pH to a high level where a variety of urinary stones may form,
including CaP salts that can act as a nidus for nucleating other salts [186,187]. The calculations shown
in Figure 11 and Table 4 demonstrate that for urine to be stable at alkaline pH would require high
concentrations of sequestering peptides, comparable to those in human milk.
5.1. Stability of Milk
The composition of milk varies greatly among species, largely reflecting the nutritional needs of the
neonate but also reflecting other physiological requirements, especially among the extremely altricial
young of marsupials and monotremes [188–190]. However, the needs of the young must be balanced
against those of the mother and it has been be argued that the protection of the mammary gland against
ectopic or pathological calcification has been an important constraint on the composition of milk [191]
because the gland goes through repeated cycles of development, lactation, and involution during the
reproductive life of the female. In eutherians, the lactose concentration is inversely related to the
concentrations of fat and protein, reflecting the caloric and growth rate requirements [192], particularly
of aquatic mammals. The highest concentrations of fat and casein are, for example, found in seal milks
where there is virtually no milk sugar and up to about 150 g casein per liter of water [193]. In primate
milks, by contrast, the osmotic pressure is mainly provided by milk sugars and the casein concentration
may be 50 times lower [194]. In milk, the main source of CaP-SLiMs are the calcium-sensitive caseins
but all caseins contain adhesive sequences to promote mutual association. As a result, all milks contain
colloidal particles called casein micelles instead of individual nanocluster complexes. These are formed
by concentrating calcium and Pi in Golgi vesicles of the mammary gland secretory cells, initially
under crowded protein conditions. The casein micelle can be regarded as an assembly of nanocluster
complexes with very similar properties to the simpler core-shell complexes [131,138,169]. For example,
a bovine milk casein micelle with a radius of 100 nm contains about 800 CaP nanoclusters and each
is sequestered by about 30 calcium-sensitive caseins providing about 50 CaP-SLiMs [149]. The αS1-
and αS2-caseins have more than one CaP-SLiM (Table 1) which means that these phosphoproteins
can either form a loop on the surface of a single CaP nanocluster or they can form bridges linking
two or more CaP nanoclusters into a larger casein micelle substructure. When casein micelles are
treated with a high concentration of a chaotropic agent they do not fully dissociate suggesting that the
caseins and CaP nanoclusters are crosslinked in the native micelle, though it is possible to argue that
the crosslinked structures are formed after the addition of the dissociating agent [195,196].
Figure 4 shows that cow’s milk serum is highly supersaturated with respect to HA but there is no
invariant ion activity product as a function of pH for this phase. There is a nearly invariant ion activity
product for ACP-2, the more stable phase of ACP, but the serum is supersaturated with respect to
ACP-2. Milk serum shows virtually the same invariant ion activity product as a solution of casein-CaP
nanoclusters [112].
The similarity of size and composition between artificial nanocluster complexes and the casein
micelle has provided the basis for calculating the partition of milk salts from first principles. When the
ab initio calculations of the partition of milk salts are compared to experiment for individual cow milk
samples with pH values in the physiological range, the agreement between theory and experiment is
very satisfactory [128]. The extension of the theory to consider calcium salt addition has also been
described [197]. The binding of the nanocluster complexes to surfaces in soft or hard tissues depends
on the nature of both the sequestering peptide, the free calcium ion concentration and the surface to
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which they may bind [198]. For example, a neutron reflectometry study was made of the structure of
interfacial layers on hydrophobic or hydrophilic surfaces formed by either co-adsorption or sequential
adsorption of nanocluster complexes prepared with β-casein 1–25 and β-casein [199]. These studies
revealed that the surface properties profoundly affected the rate of adsorption and the structure of the
interfacial layer.
Milk is remarkably stable compared to other biofluids. It has evolved in the last 250 Myr [190,200–205]
from a more typical biofluid into a concentrated source of nutrients and other bioactive substances that
are stored in the mammary gland for days, weeks, or months, depending on the species. Moreover,
the mammary tissue goes though repeated cycles of development, lactation, and involution without forming
amyloid or calcified bodies, though there are exceptions [206–209]. The stability of milk is exploited
in dairy technology. It may be boiled, or ultra-heat-treated, dried to a powder and reconstituted,
or pressure-treated at several hundred MPa and returned to atmospheric pressure without apparent ill
effect. Many structured proteins would denature irreversibly if subjected to these treatments. Milk is
highly supersaturated with respect to all basic forms of CaP, but mineral substances of any sort do
not normally precipitate from milk under physiological conditions. However, they may do so during
dairy processing operations [210]. Bovine milk contains highly amyloidogenic κ- and αS2-caseins
at very high concentrations where the formation of cytotoxic amyloid fibrils and plaque would be
expected to occur. However, amyloid formation does not normally happen. The properties of casein
lie at the heart of the scientific explanation of these remarkable properties. Caseins are IDPs and
do not undergo temperature or pressure denaturation, although there is some evidence of a small
temperature-dependent conformational transition in bovine β-casein [211]. They contain highly
effective CaP-SLiMs that can reversibly sequester CaP to prevent it from precipitating and they can
act as molecular chaperones to prevent amyloid fibril formation by themselves and other proteins,
and can limit or prevent the aggregation of unfolding globular proteins, including the globular milk
proteins β-lactoglobulin and α-lactalbumin [212,213]. Caseins were once described as “random coil
proteins with only a nutritional function” [214]. More recent research has shown them to be much
more interesting.
5.2. Stability of Blood Serum
The stability diagram has been calculated for averaged blood serum [13] from healthy
individuals [125,126]. The physiological pH is close to or a little lower than the critical pH and because
of tight homeostasis of blood pH we might not expect it to contain sequestered CaP. The point is
particularly important for human health because the cellular processes resulting in vascular calcification
are common in the final stages of kidney disease, other degenerative conditions, and sometimes,
fatal heart attacks [215–218]. We suggested [13] that a background level of sequestering phosphopeptide
was desirable to cope with physiological fluctuations in composition and pH to ensure that precipitation
of CaP arising from such fluctuations would be prevented or fully reversed when homeostasis was
restored. The major source of CaP-SLiMs is also uncertain with the principal candidates being
OPN polymorphs and fetuin A [8,141,219–221], with contributions from other phosphoproteins [178].
When the stability diagram of human serum is examined it can be seen (Figure 11) that the minimum
concentration of sequestering peptide required for stability above pHc is low compared to urine or
milk. This is mainly because it is a low phosphate biofluid in its physiological state. Nevertheless,
much higher concentrations of stabilizing phosphopeptides are required in the pathological state of
hyperphosphatemia, or physiological, post-prandial, hyperphosphatemia.
5.3. Stability of Saliva
Saliva is formed by mixing together different secretions from three major and many other minor
glands [222]. It contains the major protein groups histatins, basic, acidic, and glycosylated PRPs and
phosphoforms of statherin, together with hundreds of minor proteins, proteolytic fragments, derivatives
and peptides [223–226]. From the composition and ion equilibria calculations it was recognized to
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be supersaturated with respect to crystalline CaPs [122,227]. Nevertheless, supersaturation does not
lead directly to the formation of dental calculus [228,229]. It was proposed by Hay and Schlesinger
that the solution remained poised and metastable because of the inhibiting effect of statherin on CaP
precipitation [230]. Using an assay of the capacity of proteins to inhibit CaP precipitation, most saliva
samples were found to have an inhibitory capacity fully explained by their statherin concentration,
though in a minority of cases the inhibitory activity of the saliva was larger than expected [174].
A typical or average stability diagram of human saliva is difficult to calculate because the
composition and pH is very variable. This biofluid is not very well buffered so equilibration with
air causes the pH to rise following the loss of CO2. The results for stimulated saliva, however,
are more reproducible and for this fluid the physiological pH is above the critical pH (Equation (16)),
confirming earlier calculations. According to experiment and calculation, stimulated saliva contains
sequestered CaP [13,122] although the nature and amount of the sequestering phosphoproteins or
peptides is still not fully quantified. In Figure 12 the stability diagram for saliva [13] is superimposed
on salt partition data obtained by ultrafiltration of stimulated whole and submaxillary saliva and
stimulated and unstimulated parotid saliva [122,227]. The non-ultrafilterable calcium concentration of
unstimulated saliva at pH < 6.5 was very small but stimulated saliva has the composition and pH
expected to precipitate CaP and may do so if the concentration of sequestering phosphopeptides is
not sufficiently high to form kinetic or thermodynamically stable CaP complexes. The compositional
measurements in this work did not include proteins but in a separate study of stimulated parotid
saliva from 68 individuals, the statherin concentration range was reported to be 3.0 to 27.3 µM
(mean 12.8 ± 5.46 µM). However, according to the stability diagram, the concentration range of
CaP-SLiMs needed to form thermodynamically stable stimulated saliva is larger or much larger, in the
range 30–90 µM, depending on pH. These calculations confirm that stimulated saliva may, as we might
expect for a fluid charged with tooth remineralization, be metastable, but further work is needed to
determine in detail both the salt and protein composition of the same samples.
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lag stage before the onset of precipitation. Fundamental research, much of it from the Forsyth Dental
Centre in Boston (now Forsyth Institute) established the role of saliva in tooth remineralization and the
importance of statherin and the PRPs [64,175]. From observations of the anticariogenic effects of dairy
products, E. C. Reynolds and co-workers developed a biomimetic system using a mixture of tryptic
casein phosphopeptides and sequestered CaP in a range of tooth remineralization products [151,231].
Structural studies [152,172] showed that the biomimetic complexes were comparable to the micellar
CaP of native casein micelles and the artificial nanocluster complexes prepared with pure casein or
OPN phosphopeptides, first described in 1994 [18,24,62,110–112].
5.5. Stability of Urine
For typical urine from non-stone-formers, the physiological pH is well below the critical pH
(Equation (16)) so that normally the fluid is undersaturated with respect to CaP though it may be
supersaturated with respect to some other phases such as calcium oxalate [118–120]. Steric stabilization
of crystals by mucins, other hydrophilic proteins and polysaccharides such as chondroitin sulphate
appears to be important in urine [187]. The concentration of uropontin, a urinary polymorph
of OPN [232], is very low at about 1.9 mg L−1 and inversely proportional to urine volume [233].
Nevertheless, even at this low concentration it is effective at suppressing the precipitation of calcium
salts [234]. However, when infected by micro-organisms that secrete urease, the pH of urine may
rise to above 10 and urolithiasis involving CaP and other stones can result [160]. Because of the high
concentrations of calcium and Pi in urine compared to serum or even saliva, the concentrations of
sequestering phosphopeptides needed to form thermodynamically stable complexes with the CaP at
alkaline pH would be comparable to those in human milk (Figure 11b). This emphasizes the importance
of pH in maintaining urine as a stable solution and of steric stabilization otherwise.
5.6. Mineralization in the Extracellular Matrix of Collagenous Hard Tissues
Various mechanisms have been proposed for the mineralization of collagen by vesicles, including
pre-formed crystals of HA, precursor phase complexes and heterogeneous nucleation of calcium or Pi
ions through the interaction with extracellular non-collagenous proteins or collagen itself [43,235–240].
According to the PILP (polymer-induced liquid phase) hypothesis of L. B. Gower and collaborators [43],
an electrostatic and sterically stabilized but thermodynamically unstable liquid-like precursor phase of
CaP penetrates collagen fibers by capillary action and matures into oriented crystals of HA. Evidence
from simplified in vitro models of mineralization indicated that intrafibrillar oriented growth of HA
crystals occurred which did not require any of the non-collagenous phosphoproteins to act epitaxially in
nucleating oriented crystals of HA [241]. The polymer used in the PILP process, referred to as the process
directing agent, was usually polyaspartate but similar anionic polyelectrolytes were also used [242,243].
Model systems were devised for biomimetic mineralization of collagen sponges [241,244,245] and
models of bone [42,241,242,246], tendon [247], dentin [248] and soft tissues [249–252].
Biomimetic studies of collagen mineralization were also been made with OPN [41,159,250–254] and
interpreted as due to the PILP mechanism. A comparative study showed that collagen mineralization using
solutions containing OPN was more homogeneous, rapid and reproducible than with polyaspartate [159].
The OPN sample used in the biomimetic modelling work was not the whole protein but a mixture of
phosphopeptides from milk [41] and the same as that used to make the CaP nanocluster complexes with
OPNmix, described in Section 4.2. It comprises approximately 10 wt.% intact OPN (33.9 kDa), 57 wt.%
OPN1-149 with a molar mass of 19.8 kDa and 33 wt.% smaller phosphopeptides. The solution used to
mineralize collagen in the work of Rodriguez et al. [41] was designed [112] so that the OPNmix was
largely in the form of the equilibrium CaP nanocluster complexes described in Section 4.2. The same
OPNmix sample, in a closely similar solution with some minor changes in buffering, was used in
subsequent work [159,251–254]. Almost certainly these studies were also made with the equilibrium
CaP nanocluster complexes. Thus, the mechanism of collagen mineralization using “OPN as the process
directing agent” is different from the PILP mechanism using polyaspartate-type stabilizers, at least in
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the stability of the starting solution. It also differs because the OPNmix contains phosphopeptides
that could penetrate the collagen fibrils to potentially act epitaxially to nucleate and orient CaP [75,76],
a mechanism excluded by the PILP hypothesis [43].
It is desirable to integrate as far as possible the theory of biofluid stability with mineralization
in the extracellular matrix of hard tissues, while recognizing that many of the important details of
composition and interactions in the matrix are unknown and mineralization may begin in the smallest
intrafibrillar spaces [239]. Destabilization of a supersaturated biofluid containing complexed forms
of ACP can occur if is brought into contact with a more stable crystalline phase of CaP or if the
concentration of the stabilizing protein or polymer is reduced. This principle is illustrated in Figure 13.Crystals 2020, 10, x FOR PEER REVIEW 31 of 45 
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mineralization is suppressed. If small ions can penetrate some of the smallest collagen intrafibrillar
spaces but the stabilizing polymers are excluded in whole or part, the continuous phase in those
spaces becomes less stable and phase separation and maturation of CaP may occur. In the extrafibrillar
medium, however, phase separation is suppressed by the stabilizing polymer or protein.
6. Summary and Conclusions
6.1. Equilibrium Complexes of CaP and Phosphoproteins
Most studies of the effect of phosphoproteins on CaP precipitation have been carried out at high
ratios of CaP to phosphopeptide where metastable conditions prevail. At lower ratios, an equilibrium
complex can be formed which, at its simplest, comprises a core of amorphous CaP and a sequestering
shell of the phosphoprotein. Application of equilibrium thermodynamics shows that for an ideal
solution the condition for forming stable complexes is Kseqa0,1 ≥ 1 whereas a metastable solution results
if Kseqa0,1 < 1, where Kseq is the affinity constant for the binding of the peptide to the core CaP and a0,1
is the concentration of free phosphoprotein (i.e., the concentration remaining in the continuous phase
after forming the nanocluster complexes).
A key property of a solution of the equilibrium complexes is that it is undersaturated with respect
to the amorphous CaP of the core and as a result ACP will not precipitate even if the solution contains
arbitrarily high concentrations of total calcium and phosphate. A second key property is that while it
can exist indefinitely in a local free energy minimum, if the solution is brought into contact with a
more stable crystalline phase of CaP, the crystalline phase will grow at the expense of the CaP in the
nanocluster complexes. Both key properties have been exploited in biology.
For any given solution composition, the minimum concentration of sequestering phosphoprotein
needed for a stable solution can be calculated. A protein stability diagram is a plot of the minimum
concentration of sequestering protein versus pH; above a critical pH, pHc, the minimum concentration
is greater than zero and a proportion of the total calcium, phosphate, and phosphoprotein are present
as the nanocluster complexes.
6.2. Protein Structural Requirements for CaP Sequestration
The structural requirements for CaP sequestration are incompletely defined. The known examples
are all intrinsically disordered proteins containing several phosphorylated residues within a short
sequence, known as a CaP-SLiM or phosphate center. The affinity of the phosphoprotein for the CaP
determines the minimum effective concentration for forming the complexes. Experiments suggest that
a protein with three phosphorylated residues in a sequence of length 4 has a higher affinity for CaP
than one with the same total number of phosphorylated residues, of which none are consecutive.
6.3. Core Radius of the Nanocluster Complexes
The core radius of the nanocluster complexes depends on the ratio of the free energy of forming
the shell of sequestering phosphoproteins to the free energy of forming the core CaP multiplied by the
core surface area. The calculation can also be made for individual protein molecules in the shell or for
each individual CaP-SLiM and the area they occupy on the core surface. Steric, electrostatic, or other
lateral interactions in the shell may affect core size.
6.4. Biofluid Stability
The evidence that milk contains nanocluster complexes within the casein micelle is abundant and
compelling. There is not yet any direct experimental evidence of similar complexes in other biofluids.
A phosphopeptide from OPN, roughly residues 1–149 of the mature protein has been shown to form
the nanocluster complexes. Since OPN is present in very many tissues and biofluids and belongs to the
same paralogous group as caseins and many of the other phosphoproteins involved in the control
of biocalcification, we argue that the sequestration of CaP by SCPPs and cognate phosphoproteins
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is a more general mechanism through which physiological fluids can be maintained in a stable state.
In fact, the ion activity product in fresh saliva and blood serum displays a striking similarity to that
seen in a solution with CaP nanoclusters sequestered by OPN peptides, even though the sequestering
phosphopeptides may be different in each fluid (Figure 4). The ion activity products of the CaP,
measured by the invariant pKS values for fresh saliva, blood serum, and a pure nanocluster solution
prepared from OPN peptides are also similar at 9.26 ± 0.35, 9.27 ± 0.13 and 9.12 ± 0.05, respectively.
These ion activity products are statistically indistinguishable. It is hard to escape the conclusion that
blood, and saliva contain similar forms of sequestered ACP. When sequestered within nanocluster,
the CaP remains bio-available and can be deposited on mineral surfaces. Thus, allowing physiological
fluids to maintain the integrity of mineral phases with which they are in contact, without causing the
unwanted mineralization of soft tissue. The specific roles of the SCPPs casein and OPN have been
highlighted; however, other CaP-SLiM-containing SCPPs present in physiological fluids may exert the
same sequestration effect. Thus, sequestration of CaP nanoclusters may provide a general mechanism
of in vivo stabilization of biofluids and provide the means to create artificial physiological fluids that
more closely mimic their natural counterparts.
6.5. Artificial and Biomimetic Materials
There are many possible applications of the science described in this review. These include, but are
not limited to, biomimetic materials for the repair of bone fractures and demineralized teeth. Artificial
biofluids with superior shelf-life that can be used in the irrigation of wounds during and after surgery,
the irrigation of joints to help remove erosive crystals from synovial spaces, artificial serum for rapid
rehydration of dehydrated patients, a superior kidney dialysis fluid that reproduces more closely the
composition of blood serum and a growth medium for tissue engineering applications that can support
the in vitro growth of mineralized tissues. Here the relation between the ACP protein complex and
interfacial behavior is crucial not only for the understanding of biomineralization, but also for the
preparation of nano-structured surfaces by means of controlled deposition.
6.6. Basic Research Needs
Fluids that are stable and have arbitrarily high concentrations of calcium and phosphate have
many potential applications. Here we limit ourselves to a few that are still closely related to the topic
of the control of biocalcification.
Is it possible to design phosphopeptides that will suppress or reverse ectopic or other forms
of pathological calcification when they are present at low concentration? The effective concentration
at which phosphopeptides can stabilize biofluids is determined by their affinity of binding to
CaP. Systematic studies are therefore required of the relationship between peptide sequence and
phosphorylation and the thermodynamics of CaP nanocluster sequestration.
Is it possible to design nanocluster complexes that form rapidly and have a specified size and
structure? There is still a lack of knowledge of the structure of individual nanoclusters, the conformation
and dynamics of the peptide chains and the type of disorder in the core. Some peptides form an
equilibrium complex in hours while others take several days. Is it possible to reduce the equilibration
time to seconds or less? We do not yet know the detailed structure of the peptide/protein shell and how
the peptides/proteins are attached and oriented at the interface! The CaP nanoclusters are stabilized by
a rather specific interaction between phosphorylation sites on the peptide with the CaP which gives
directionality to the interaction. Here, further applications of advanced scattering and spectroscopic
techniques and studies of the effects of the sample environment will be rewarded by rapid progress in
our fundamental understanding.
Is it possible to make plant derived foods and beverages that have the same remarkable
stability as casein-based products? It is still a challenge to make plant-based beverages with the same
high content of calcium as milk but with high stability.
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Is it possible to design a biomimetic remineralization system that can be directed to the sites
where mineral loss is occurring? We have only briefly touched on the mechanisms of biomineralization
and how the presence of the nanocluster complexes could provide CaP to ensure that tooth and bone
mineralization are maintained. A biomimetic delivery system directed to sites of mineralization,
possibly in the form of vesicles [255] containing suitable nanocluster complexes would be a long-term
goal. Here, inverse lipid-water phases such as bi-continuous cubic phase dispersions (cubosomes),
could be useful because of their higher loading capacity and structure with intertwined water channels
that can accommodate CaP [256].
How is CaP transferred from the biofluid to the bone tissue? In principle, at least, the total
calcium and phosphate concentrations could be made very high and sequestering peptide sequences
could be engineered and optimized for intrafibrillar mineralization of the extracellular matrix of bone,
for example [41]. Here there is knowledge gap in terms of the mechanism of transport and attachment
of complexes to the site of biomineralization. We do not yet understand well enough how and under
what conditions biomineralization could occur. In fact, the detailed understanding on how and in
which form CaP is transferred from circulating biofluids to the extracellular matrix of mineralizing
tissues is still incomplete [1,43,255,257–260]. Increased effort is needed on model systems of greater
complexity to simulate processes in the extracellular matrix and material science studies on glass
ionomer cements, teeth and bones [261].
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